{"denoms":[{"counts":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"203"}],"units":"Participants"}],"groups":[{"description":"Patients apply 1 spoonful of baclofen-amitriptyline hydrochloride-ketamine gel topically to each area of pain, numbness, and/or tingling on the feet and/or hands twice daily for 4 weeks. Baclofen/amitriptyline/ketamine gel: Applied topically.","id":"BG000","title":"Baclofen-amitriptyline Hydrochloride-ketamine"},{"description":"Patients apply 1 spoonful of placebo gel topically to each area of pain, numbness, and/or tingling on the feet and/or hands twice daily for 4 weeks. Placebo: Applied topically","id":"BG001","title":"Placebo"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"41","upperLimit":"83","value":"59.5"},{"groupId":"BG001","lowerLimit":"31","upperLimit":"86","value":"62"},{"groupId":"BG002","lowerLimit":"31","upperLimit":"86","value":"61"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"66"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"126"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"42"},{"groupId":"BG002","value":"77"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"101"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"203"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}